about
Vasculogenic hydrogel enhances islet survival, engraftment, and function in leading extrahepatic sitesCurrent challenges for cancer vaccine adjuvant development.A DNA Vaccine Encoding SA-4-1BBL Fused to HPV-16 E7 Antigen Has Prophylactic and Therapeutic Efficacy in a Cervical Cancer Mouse ModelLocal immunomodulation Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptanceLocalized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic ImmunosuppressionA Novel Form of 4-1BBL Prevents Cancer Development via Nonspecific Activation of CD4+ T and Natural Killer CellsPancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilegeImmune checkpoint CD47 molecule engineered islets mitigate instant blood-mediated inflammatory reaction and show improved engraftment following intraportal transplantation
P50
Q33758370-C937DF75-B10E-4C75-A976-FD527EB93054Q48160317-F5A1FD8E-729E-44BC-A77F-916571C69700Q61816603-E8B15896-B0C8-4FA8-83D3-C12272F519D4Q88985536-50FD24C3-B035-407F-8D5E-FF8CB7271DCFQ91610248-580CFD46-AE3A-46A7-B414-891112E60ADFQ91632541-DB84F150-34E7-4615-B65C-A9CD942BFAF5Q92077204-5A3832F9-35FD-4875-B06D-BA902778C5E4Q93333217-B30D7CF2-6154-4823-8171-1DB7564EE29C
P50
description
investigador
@es
researcher
@en
name
Haval Shirwan
@en
type
label
Haval Shirwan
@en
prefLabel
Haval Shirwan
@en
P31
P496
0000-0002-1657-9470